Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/CE

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/CE History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/CE(x) 2.651.973.003.432.31

What is the latest EV/CE ratio of NATCO PHARMA ?

The latest EV/CE ratio of NATCO PHARMA is 2.65 based on Mar2024 Consolidated results.
Year EV/CE
Mar20242.65
Mar20231.97
Mar20223.00
Mar20213.43
Mar20202.31

How is EV/CE of NATCO PHARMA Trending?

Years EV/CE % Change
Mar2024 2.65
34.52
Mar2023 1.97
-34.33
Mar2022 3
-12.54
Mar2021 3.43
48.48
Mar2020 2.31 -

Other Financial Ratios of NATCO PHARMA


Compare EV/CE ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹23,464.8 Cr -5.6% -9.1% 66.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,145.0 Cr -2% 2.1% 42.6% Stock Analytics
DIVIS LABORATORIES ₹156,280.0 Cr -3.5% -3.4% 49.9% Stock Analytics
CIPLA ₹120,379.0 Cr -2.6% -0.6% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹112,701.0 Cr -2.7% 8.9% 14.2% Stock Analytics
ZYDUS LIFESCIENCES ₹96,774.5 Cr -1% -1.7% 36.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.6%

-9.1%

66.6%

SENSEX

-0.4%

-3.7%

7.9%


You may also like the below Video Courses